Testosterone MDL Judge Picks 1st 8 AndroGel Bellwether Cases

(August 5, 2016, 11:57 AM EDT) -- CHICAGO — The Illinois federal judge overseeing the testosterone multidistrict litigation on Aug. 4 identified eight AbbVie heart attack, stroke and blood clot cases for the MDL’s first bellwether trials starting next year (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill., Eastern Div.)....

Attached Documents

Related Sections